Headed to ACS San Diego? Join us for Happy Hour!
← Back to glossary

Homology Modeling

Method
Method
Method

Homology modeling, also known as comparative modeling, is a computational technique used to predict the three-dimensional structure of a protein based on the known structures of homologous proteins (templates). It involves the following steps:

  1. Template Identification: Identifying one or more known protein structures (templates) with significant sequence similarity to the target protein.
  2. Sequence Alignment: Aligning the target protein sequence with the template protein sequences.
  3. Model Building: Constructing a 3D model of the target protein based on the alignment and the structures of the templates.
  4. Model Refinement: Refining the model to improve its accuracy, often using energy minimization and molecular dynamics simulations.
  5. Model Validation: Assessing the quality of the model using various validation tools and metrics.

Importance in Computational Drug Discovery

  1. Structure Prediction: Homology modeling provides structural information for proteins whose structures are not experimentally determined, aiding in understanding their function and interactions.
  2. Target Identification: Structural models of target proteins can be used to identify potential binding sites for drug molecules.
  3. Ligand Docking: Homology models serve as receptors for molecular docking studies, predicting how small molecules interact with the target protein.
  4. Virtual Screening: Structural models enable virtual screening of large libraries of compounds to identify potential drug candidates.
  5. Rational Drug Design: Detailed structural information from homology models facilitates the rational design of molecules with improved binding affinity and specificity.

Key Tools

Literature

  1. "Homology Modeling in Drug Discovery: Overview, Current Applications, and Future Perspectives"
    1. Publication Date: 2018-10-08
    2. DOI: 10.1111/cbdd.13388
    3. Summary: Discusses the principles of homology modeling, its applications in drug discovery, and future perspectives in the field.
  2. "Homology Modeling in Drug Discovery: Current Trends and Applications"
    1. Publication Date: 2009-07-01
    2. DOI: 10.1016/j.drudis.2009.04.006
    3. Summary: Reviews the current developments in homology modeling and its successful application in different stages of drug discovery.
  3. "Homology Modeling in Drug Discovery – An Update on the Last Decade"
    1. Publication Date: 2017-08-31
    2. DOI: 10.2174/1570180814666170110122027
    3. Summary: Provides an update on advancements in homology modeling techniques over the last decade and their impact on drug discovery.
  4. "Combined Approach of Homology Modeling, Molecular Dynamics, and Docking: Computer-Aided Drug Discovery"
    1. Publication Date: 2019-10-25
    2. DOI: 10.1515/psr-2019-0066
    3. Summary: Reviews recent works employing a combined approach of homology modeling, molecular dynamics, and docking for structure-based drug design.
  5. "Homology Modeling: An Important Tool for Drug Discovery"
    1. Publication Date: 2015-08-03
    2. DOI: 10.1080/07391102.2014.971429
    3. Summary: Discusses the fundamentals and current state of homology modeling techniques and their applications in drug discovery.
  6. "From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds"
    1. DOI: 10.1007/978-1-0716-1209-5_15
    2. Summary: Describes a structure-based approach integrating homology modeling for hit identification and drug repurposing.
  7. "Homology Modeling of Coronavirus Structural Proteins and Molecular Docking of Potential Drug Candidates for the Treatment of COVID-19"
    1. Publication Date: 2020-08-02
    2. DOI: 10.2174/2666796701999200802040704
    3. Summary: Models coronavirus proteins and docks potential drug candidates, identifying inhibitors like remdesivir, lopinavir, and ritonavir.
  8. "Fragment-Based Virtual Screening Identifies Novel Leads Against Plasmepsin IX (PlmIX) of Plasmodium falciparum: Homology Modeling, Molecular Docking, and Simulation Approaches"
    1. Publication Date: 2024-05-23
    2. DOI: 10.3389/fphar.2024.1387629
    3. Summary: Uses homology modeling and virtual screening to identify novel inhibitors for Plasmepsin IX of Plasmodium falciparum.
  9. "Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2"
    1. Publication Date: 2018-07-24
    2. DOI: 10.3389/fchem.2018.00279
    3. Summary: Provides insights into structural basis of substrate specificity for ASCT2, aiding in the design of selective inhibitors.
  10. "Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach"
    1. Publication Date: 2021-05-23
    2. DOI: 10.3390/molecules26113115
    3. Summary: Identifies potential ABCG2 inhibitors through a homology modeling and docking approach.